Provided By PR Newswire
Last update: Aug 27, 2020
NEW YORK, Aug. 26, 2020 /PRNewswire/ --
Cancer Genetics, Inc. (NASDAQ: CGIX)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of CGIX with StemoniX, Inc.
If you are a JCAP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Jernigan Capital, Inc. (NYSE: JCAP, JCAP-PB)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of JCAP to an affiliate of NexPoint Advisors, L.P. for $17.30 per share.
If you are a JCAP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of MNTA to JNJ for $52.50 per share in cash.
If you are a MNTA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
NTN Buzztime, Inc. (NYSE: NTN)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of NTN with Brooklyn ImmunoTherapeutics LLC.
If you are a NTN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Principia Biopharma Inc. (NASDAQ: PRNB)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of PRNB to Sanofi for $100 per share.
If you are a PRNB investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of SBPH to F-star Therapeutics, Limited.
If you are a SPBH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Varian Medical Systems, Inc. (NYSE: VAR)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of VAR to Siemens Healthineers AG.
If you are a VAR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Yintech Investment Holdings Limited (NASDAQ: YIN)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of YIN to members of YIN management.
If you are a YIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
SOURCE Lifshitz & Miller Law Firm